PMC:7396557 / 22646-22829 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T99","span":{"begin":67,"end":71},"obj":"Body_part"},{"id":"T100","span":{"begin":114,"end":126},"obj":"Body_part"},{"id":"T101","span":{"begin":137,"end":144},"obj":"Body_part"},{"id":"T102","span":{"begin":140,"end":144},"obj":"Body_part"}],"attributes":[{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma62870"},{"id":"A101","pred":"fma_id","subj":"T101","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A102","pred":"fma_id","subj":"T102","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Blocks p-38 MAPK and NF-κB 65 pathways (Liu et al., 2014); reduces IL-1, IL-6 and TNF-α level, improves CD4+/CD8+ T lymphocyte ratio and NK cell relative activity (Teng et al., 2012)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T184","span":{"begin":25,"end":29},"obj":"http://purl.obolibrary.org/obo/CLO_0001825"},{"id":"T185","span":{"begin":104,"end":107},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T186","span":{"begin":109,"end":112},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T187","span":{"begin":137,"end":144},"obj":"http://purl.obolibrary.org/obo/CL_0000623"},{"id":"T188","span":{"begin":154,"end":162},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Blocks p-38 MAPK and NF-κB 65 pathways (Liu et al., 2014); reduces IL-1, IL-6 and TNF-α level, improves CD4+/CD8+ T lymphocyte ratio and NK cell relative activity (Teng et al., 2012)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T143","span":{"begin":21,"end":23},"obj":"Chemical"},{"id":"T146","span":{"begin":67,"end":69},"obj":"Chemical"},{"id":"T148","span":{"begin":73,"end":75},"obj":"Chemical"}],"attributes":[{"id":"A143","pred":"chebi_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/CHEBI_141424"},{"id":"A144","pred":"chebi_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/CHEBI_25573"},{"id":"A145","pred":"chebi_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/CHEBI_1224"},{"id":"A146","pred":"chebi_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A147","pred":"chebi_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A148","pred":"chebi_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A149","pred":"chebi_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"Blocks p-38 MAPK and NF-κB 65 pathways (Liu et al., 2014); reduces IL-1, IL-6 and TNF-α level, improves CD4+/CD8+ T lymphocyte ratio and NK cell relative activity (Teng et al., 2012)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T31","span":{"begin":12,"end":16},"obj":"http://purl.obolibrary.org/obo/GO_0004707"}],"text":"Blocks p-38 MAPK and NF-κB 65 pathways (Liu et al., 2014); reduces IL-1, IL-6 and TNF-α level, improves CD4+/CD8+ T lymphocyte ratio and NK cell relative activity (Teng et al., 2012)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"495","span":{"begin":21,"end":26},"obj":"Gene"},{"id":"496","span":{"begin":67,"end":71},"obj":"Gene"},{"id":"497","span":{"begin":73,"end":77},"obj":"Gene"},{"id":"498","span":{"begin":82,"end":87},"obj":"Gene"},{"id":"499","span":{"begin":104,"end":107},"obj":"Gene"},{"id":"500","span":{"begin":109,"end":112},"obj":"Gene"}],"attributes":[{"id":"A495","pred":"tao:has_database_id","subj":"495","obj":"Gene:4790"},{"id":"A496","pred":"tao:has_database_id","subj":"496","obj":"Gene:3552"},{"id":"A497","pred":"tao:has_database_id","subj":"497","obj":"Gene:3569"},{"id":"A498","pred":"tao:has_database_id","subj":"498","obj":"Gene:7124"},{"id":"A499","pred":"tao:has_database_id","subj":"499","obj":"Gene:920"},{"id":"A500","pred":"tao:has_database_id","subj":"500","obj":"Gene:925"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Blocks p-38 MAPK and NF-κB 65 pathways (Liu et al., 2014); reduces IL-1, IL-6 and TNF-α level, improves CD4+/CD8+ T lymphocyte ratio and NK cell relative activity (Teng et al., 2012)."}

{"project":"2_test","denotations":[{"id":"32848729-25511395-39628364","span":{"begin":52,"end":56},"obj":"25511395"}],"text":"Blocks p-38 MAPK and NF-κB 65 pathways (Liu et al., 2014); reduces IL-1, IL-6 and TNF-α level, improves CD4+/CD8+ T lymphocyte ratio and NK cell relative activity (Teng et al., 2012)."}